![Mark A. Schlossberg](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark A. Schlossberg
No open positions remaining
Profile
Mark A. Schlossberg served as an Independent Director at ImmunoCellular Therapeutics Ltd. from 2015 to 2017.
He was a Director at Angiologix, Inc. and a Vice President at Amgen, Inc. from 2004 to 2011.
He also worked as a Principal at R.J.
Reynolds Tobacco Holdings, Inc. and as a Vice President-Law at Medtronic Trading Ltd. Additionally, he served as the Secretary, Senior Vice President & General Counsel at Impax Laboratories LLC from 2012 to 2018 and as the Secretary, Senior VP-Legal & General Counsel at Cytokinetics, Inc. from 2011 to 2022.
Schlossberg received his undergraduate degree from the University of Southern California and his graduate degree from Emory University School of Law.
Former positions of Mark A. Schlossberg
| Companies | Position | End |
|---|---|---|
| CYTOKINETICS, INCORPORATED | General Counsel | 13/05/2022 |
Impax Laboratories LLC
 Impax Laboratories LLC Pharmaceuticals: MajorHealth Technology Engages in development, manufacture and commercialization of generic and branded prescription pharmaceutical products | General Counsel | 01/05/2018 |
| EOM PHARMACEUTICALS HOLDINGS, INC. | Director/Board Member | 15/08/2017 |
| AMGEN INC. | Corporate Officer/Principal | 01/05/2011 |
R.J. Reynolds Tobacco Holdings, Inc.
 R.J. Reynolds Tobacco Holdings, Inc. TobaccoConsumer Non-Durables Manufactures tobacco products | Corporate Officer/Principal | - |
Training of Mark A. Schlossberg
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
64
1st degree connections
10
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 10 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
R.J. Reynolds Tobacco Holdings, Inc.
R.J. Reynolds Tobacco Holdings, Inc. TobaccoConsumer Non-Durables Manufactures tobacco products | Consumer Non-Durables |
Impax Laboratories LLC
Impax Laboratories LLC Pharmaceuticals: MajorHealth Technology Engages in development, manufacture and commercialization of generic and branded prescription pharmaceutical products | Health Technology |
Cytokinetics, Inc.
 Cytokinetics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes novel drug products | Health Technology |
ImmunoCellular Therapeutics Ltd.
 ImmunoCellular Therapeutics Ltd. BiotechnologyHealth Technology Operates as a clinical stage pharmaceutical company | Health Technology |
Angiologix, Inc.
 Angiologix, Inc. Electronic Equipment/InstrumentsElectronic Technology Provides cardiovascular diagnostic products | Electronic Technology |
University of Southern California
 University of Southern California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Medtronic Trading Ltd. | |
Diageo India Pvt Ltd.
 Diageo India Pvt Ltd. Beverages: AlcoholicConsumer Non-Durables Manufactures and wholesales wines and spirits | Consumer Non-Durables |
Emory University School of Law
 Emory University School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- Mark A. Schlossberg
